Brief: Sunesis Announces Proposed Public Offering Of Common Stock
July 28 (Reuters) - Sunesis Pharmaceuticals Inc SNSS.O :
* SUNESIS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
* SUNESIS PHARMACEUTICALS - ANTICIPATES USING NET PROCEEDS
FROM
PROPOSED OFFERING TO FUND ONGOING DEVELOPMENT OF PDK1 INHIBITOR
SNS-510
Source text for Eikon: ID:nGNXbbvS7
Further company coverage: SNSS.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update